Company / Current Assets per Share
KalVista Pharmaceuticals, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.68
FY2025
5-year range
$4.55 / $14.81
FY2021-FY2025
Trend
+25.0%
vs FY2024
Sector context
#125 of 210
Health Care
What the data says
At $5.68, KalVista Pharmaceuticals, Inc.'s current assets per share ranks #125 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 3 years of decline, reaching $5.68.
Based on SEC 10-K filings.
5.68 in FY2025 with a 5-year CAGR of +2.1%.
Improved from $4.68 to $5.68 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.5%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
#125 of 210 in Health CareTop 60% of 210This company $5.68 Sector average $134.38
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 25.0% year-over-year.
- Ranks #125 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2021.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.68 | +25.0% |
| FY2024 | $4.55 | -3.0% |
| FY2023 | $4.68 | -40.9% |
| FY2022 | $7.93 | -46.5% |
| FY2021 | $14.81 | +188.5% |
| FY2020 | $5.13 | -52.0% |
| FY2019 | $10.70 | +75.0% |
| FY2018 | $6.11 | +84.5% |
| FY2017 | $3.31 | -37.6% |
| FY2016 | $5.31 | -97.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026